{"url_path":"/sec/ctxr/8-k/2026-06-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1506251/0001213900-26-063531-index.html","accession_number":"0001213900-26-063531","cik":"0001506251","ticker":"CTXR","issuer_name":"Citius Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1506251/0001213900-26-063531-index.html","primary_entity_key":"0001506251","primary_entity_name":"Citius Pharmaceuticals, Inc."},"word_count":83,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\nExhibit No.\n \nDescription\n\n99.1\n \n[Press release, dated June 1, 2026.](ea029290401ex99-1.htm)\n\n104\n \nCover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).\n\n \n\n1\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\nDate: June 1, 2026\n**CITIUS PHARMACEUTICALS, INC.**\n\n \n \n \n\n \nBy:\n/s/ Leonard Mazur                           \n\n \n \nLeonard Mazur\n\n \n \nChairman and Chief Executive Officer\n\n \n\n2"}